Inventiva Secures EUR 21.4 Mln, Seals First Tranche Of Multi-Tranche Financing

T-Reuters

2024/12/16

Inventiva SA :Secures €21.4 Million And Completes The First Tranche Of The Previously Announced Multi-Tranche Financing Of Up To €348 Million.Additional Cash Requirements Estimated At €120 Million To €130 Million.Proceeds To Advance Phase Iii Nativ3 Clinical Trial.Appoints Mark Pruzanski As Chairman And Srinivas Akkaraju To Board.Company Estimates Financing Operations Until Mid-Q3 2025.Net Proceeds Of €20.1 Million To Fund Clinical Program And Corporate Purposes.Board Approves Second Phase Of Tranche 1 For €21.4 Million.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2491365173"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2491365173\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2491365173?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-12-16 15:59","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2491365173","market":"hk","top_or_hot":-1,"title":"Inventiva Secures EUR 21.4 Mln, Seals First Tranche Of Multi-Tranche Financing","media":"T-Reuters","content":"<html><body><p>Inventiva SA <ivaa.pa>:Secures €21.4 Million And Completes The First Tranche Of The Previously Announced Multi-Tranche Financing  Of Up To €348 Million.Additional Cash Requirements Estimated At €120 Million To €130 Million.Proceeds To Advance Phase Iii Nativ3 Clinical Trial.Appoints Mark Pruzanski As Chairman And Srinivas Akkaraju To Board<a href=\"https://laohu8.com/S/02403\">.C</a>ompany Estimates Financing Operations Until Mid-Q3 2025.Net Proceeds Of €20.1 Million To Fund Clinical Program And Corporate Purposes.Board Approves Second Phase Of Tranche 1 For €21.4 Million.</ivaa.pa></p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Inventiva Secures EUR 21.4 Mln, Seals First Tranche Of Multi-Tranche Financing</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nInventiva Secures EUR 21.4 Mln, Seals First Tranche Of Multi-Tranche Financing\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086160438\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a113a995fbbc262262d15a5ce37e7bc5);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">T-Reuters </p>\n<p class=\"h-time\">2024-12-16 15:59</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p>Inventiva SA <ivaa.pa>:Secures €21.4 Million And Completes The First Tranche Of The Previously Announced Multi-Tranche Financing  Of Up To €348 Million.Additional Cash Requirements Estimated At €120 Million To €130 Million.Proceeds To Advance Phase Iii Nativ3 Clinical Trial.Appoints Mark Pruzanski As Chairman And Srinivas Akkaraju To Board<a href=\"https://laohu8.com/S/02403\">.C</a>ompany Estimates Financing Operations Until Mid-Q3 2025.Net Proceeds Of €20.1 Million To Fund Clinical Program And Corporate Purposes.Board Approves Second Phase Of Tranche 1 For €21.4 Million.</ivaa.pa></p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4139","symbol_name":"生物科技","start_time":0,"source_url":"https://www.trkd.thomsonreuters.com","article_id":"2491365173","we_media_id":"1086160438","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2491365173","pubTimestamp":1734335980,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"T-Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1086160438","head_image":"https://static.tigerbbs.com/a113a995fbbc262262d15a5ce37e7bc5"},"summary":"Inventiva SA :Secures 21.4 Million And Completes The First Tranche Of The Previously Announced Multi-Tranche Financing  Of Up To 348 Million.Additional Cash Requirements Estimated At 120 Million To 130 Million.Proceeds To Advance Phase Iii Nativ3 Clinical Trial.Appoints Mark Pruzanski As Chairman And Srinivas Akkaraju To Board.Company Estimates Financing Operations Until Mid-Q3 2025.Net Proceeds Of 20.1 Million To Fund Clinical Program And Corporate Purposes.Board Approves Second Phase Of Tranche 1 For 21.4 Million.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4139":"生物科技","IVA":"Inventiva S.A."},"translate_title":"Inventiva获得2140万欧元，完成第一笔多笔融资","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"IVA":0.9},"content_text":"Inventiva SA :Secures €21.4 Million And Completes The First Tranche Of The Previously Announced Multi-Tranche Financing  Of Up To €348 Million.Additional Cash Requirements Estimated At €120 Million To €130 Million.Proceeds To Advance Phase Iii Nativ3 Clinical Trial.Appoints Mark Pruzanski As Chairman And Srinivas Akkaraju To Board.Company Estimates Financing Operations Until Mid-Q3 2025.Net Proceeds Of €20.1 Million To Fund Clinical Program And Corporate Purposes.Board Approves Second Phase Of Tranche 1 For €21.4 Million.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}